인쇄하기
취소

Conference for Hycamptin, a new cervical cancer therapy.

Published: 2007-05-02 06:59:00
Updated: 2007-05-02 06:59:00
GSK Korea held a lunching symposium for Hycamptin, a new cervical cancer therapy, at the conference of Korean Gynecologic Oncology Group.

The symposium took place at Grand hotel, Busan Haewoon dae on April 19, presenting a Hycamptin therapy in combination with the standard cisplatin to improve a prevention of metastasis, recurrence and survival times compared to the single cisplatin medicati...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.